|
|
Financial Disclosure
|
Joseph S. Bubalo, PharmD, has indicated that he has no relevant affiliations or financial relationships with a commercial interest to disclose. The following reviewer, Renee A. Bellanger, PharmD, hereby states that she does not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
|
Accreditation Statements
|
|
|
Target Audience
|
This accredited activity has been designed for pharmacists.
|
How to Earn Credit
|
During the period March 26, 2015 through March 31, 2017, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the posttest and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on Submit Posttest at the bottom of the page. Your posttest will automatically be graded. If you successfully complete the posttest (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest. To receive Credit you must provide your date of birth and NABP number. All credit information will be uploaded into CPE monitor within 30 days.
|
Goal
|
The goal of this activity is to increase the awareness, understanding, and the ability of pharmacists in hospital/health-systems, long-term care, and oncology/specialty settings to assess, manage, and support the treatment of anemia in individuals with cancer who are receiving myelosuppressive chemotherapy.
|
Educational Objectives
|
Upon completion of this activity, participants should be better able to:
|
|
Required Computer Hardware/Software
|
Please ensure the computer system you plan to use meets the following minimum requirements:
|
|
|
|